Long-COVID depression (LoCODe)
Today we received a rejection of our BMBF-application “LoCODe”.
Topic: i) To understand and characterise long-COVID depression (LoCODe) clinically and via biomarkers that discern depressive patients with and without prior SARS-CoV-2 infection. ii) To enable stratified therapeutic observations and targeted interventional trials. iii) To discern adaptational or incidental depression from a post infectious depressive patient subgroup by behavior, sleep patterns, neuro-vascular and immunological markers and their interrelation. iv) To relate and compare to similar mechanisms in atypical/ depression subtypes without prior SARS-CoV-2.
Our application was a multi-center collaboration spanning the Universities Jena, Lübeck, Magdeburg, Halle and Berlin.